…
Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Cann American Corp (CNNA.US) on the OTC Pink are limited and its current business operations are not clearly documented. If the company remains active in cannabis or related services, long-term drivers that could support growth include legalization trends and rising consumer demand, which may attract investors seeking sector exposure.
Key risks are limited transparency and outdated filings, very low liquidity on the OTC Pink market, regulatory uncertainty in cannabis markets, and potential capital constraints or dilution.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
| Income before tax | - | - | - | -0.01M | -0.00M |
| Net income | - | - | - | -0.01M | -0.00M |
| Selling general administrative | - | - | - | 0.09M | 0.02M |
| Gross profit | - | - | - | 0.09M | 0.02M |
| Ebit | -0.15M | -0.20M | -0.01M | -0.01M | -0.00M |
| Operating income | - | - | - | -0.01M | -0.00M |
| Interest expense | - | - | 0.00M | 0.00M | 0.00M |
| Total revenue | - | - | - | 0.12M | 0.03M |
| Total operating expenses | - | - | - | 0.12M | 0.03M |
| Cost of revenue | - | - | - | 0.03M | 0.01M |
| Net income from continuing ops | - | - | - | -0.01M | -0.00M |
| Net income applicable to common shares | 3.82M | 10.54M | -0.25M | -0.01M | -0.00M |
| Breakdown | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
| Total assets | - | - | - | 0.19M | 0.20M |
| Other current assets | 0.05M | 0.20M | - | - | - |
| Total liab | - | - | - | 0.20M | 0.20M |
| Total stockholder equity | - | - | - | -0.01M | -0.00M |
| Other current liab | 2.51M | 6.45M | - | - | - |
| Common stock | 0.95M | 0.93M | 0.90M | 0.90M | 0.90M |
| Retained earnings | -8.37M | -12.19M | -5.11M | -4.86M | -4.85M |
| Good will | - | - | - | 0.19M | 0.19M |
| Other assets | - | - | 0.00M | - | - |
| Cash | - | - | - | 0.00M | 0.00M |
| Total current liabilities | 2.88M | 6.85M | 0.00M | 0.20M | - |
| Short term debt | - | - | - | 0.20M | - |
| Short long term debt | - | - | - | 0.20M | - |
| Property plant equipment | - | - | 0.00M | 0.01M | 0.01M |
| Total current assets | 0.07M | 0.21M | 0.05M | 0.00M | 0.00M |
| Net tangible assets | -2.81M | -6.65M | 0.04M | -0.19M | -0.19M |
| Long term debt | - | - | - | - | 0.20M |
| Accounts payable | - | - | 0.00M | 0.00M | - |
| Breakdown | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2020-02-29 | 2019-02-28 | 2018-02-28 |
| Change to liabilities | 0.00M | -0.06M | -0.00M | 0.00M | 0.00M |
| Total cashflows from investing activities | - | - | 0.24M | 0.24M | -0.20M |
| Net borrowings | 0.10M | 0.22M | 0.00M | 0.00M | 0.20M |
| Total cash from financing activities | 0.01M | 0.28M | 0.05M | 0.05M | 0.20M |
| Change to operating activities | 0.15M | -0.09M | -0.09M | -0.09M | - |
| Net income | 3.82M | 10.54M | -0.25M | -0.01M | -0.00M |
| Change in cash | 0.01M | -0.07M | 0.04M | -0.00M | 0.00M |
| Total cash from operating activities | 0.01M | -0.34M | -0.24M | -0.00M | 0.00M |
| Depreciation | - | - | 0.01M | 0.00M | 0.00M |
| Other cashflows from financing activities | -0.09M | 0.05M | 0.05M | 0.05M | - |
| Change to netincome | -4.00M | -11.01M | -0.00M | -0.00M | -0.00M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| CNNA Cann American Corp |
- -% |
0.01 | - | - | 0.03 | 0.00 | -0.00 |
| MKKGY Merck KGaA ADR |
-0.68 2.09% |
31.83 | 21.25 | 14.93 | 3.10 | 2.14 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
163.45 | 24.86 | 15.11 | 3.13 | 1.98 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.38 1.77% |
21.79 | - | 10.96 | 0.01 | 1.20 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.05 | - | 10.66 | 0.01 | 1.16 | 23.11 |
Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.
| Name | Title | Year Born |
|---|---|---|
| Mr. Alexander Woods-Leo | CEO, Pres, Sec. & Director | NA |
| Mr. Jason R. Tucker | CFO, CEO, Secretary, Treasurer & Director | 1977 |
| Mr. Michael G. Kramer | President, COO and Director | 1979 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.